BioSyent Inc. Announces Quarterly Dividend of $0.05 (CVE:RX)

Key Points

• BioSyent Inc. has declared a quarterly dividend of $0.05 per share, which will be paid to stockholders of record on August 29th.
• The company's current dividend yield stands at 1.7%, reflecting its commitment to returning value to shareholders.
• BioSyent's stock opened at C$11.59, with a market capitalization of C$132.56 million and a 12-month price range between C$9.20 and C$12.13.

BioSyent Inc. (CVE:RX - ) announced a quarterly dividend on Thursday, August 21st, RTT News reports. Stockholders of record on Friday, August 29th will be paid a dividend of 0.05 per share on Monday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%.

BioSyent Stock Performance

Shares of RX stock opened at C$11.59 on Friday. The business's 50-day moving average price is C$11.58 and its 200-day moving average price is C$11.23. BioSyent has a 12 month low of C$9.20 and a 12 month high of C$12.13. The firm has a market capitalization of C$132.56 million, a price-to-earnings ratio of 18.81 and a beta of 0.93. The company has a current ratio of 3.92, a quick ratio of 6.91 and a debt-to-equity ratio of 2.90.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.